In patients with depression 88% of the ketamine group had achieved remission of suicidal ideation 90 minutes post-infusion, according to the investigators.
All articles by Laurell Haapanen
Rapastinel is being evaluated as a monotherapy for MDD as well as for suicidality in MDD.
Latest News Your top articles for Saturday
Haymarket Medical NetworkTop Picks